Company Filing History:
1 out of 53 
1 out of 3,923 
Years Active: 2020
Title: The Innovative Contributions of Elisabetta Marangoni
Introduction
Elisabetta Marangoni is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug combinations. Her work focuses on enhancing the efficacy of cancer treatments through novel approaches.
Latest Patents
Elisabetta holds a patent for a groundbreaking combination of a MCL-1 inhibitor and a taxane compound. This patent, titled "Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereof," outlines a combination that includes a MCL-1 inhibitor and a taxane compound, along with its compositions and uses. This innovative approach has the potential to improve treatment outcomes for patients.
Career Highlights
Throughout her career, Elisabetta has worked with notable companies in the pharmaceutical industry, including Les Laboratories Servier and Novartis AG. Her experience in these organizations has allowed her to contribute to significant advancements in drug development and therapeutic strategies.
Collaborations
Elisabetta has collaborated with esteemed colleagues such as Dale Porter and Ensar Halilovic. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing her innovative contributions.
Conclusion
Elisabetta Marangoni's work exemplifies the impact of innovation in the pharmaceutical industry. Her patent and collaborations highlight her commitment to advancing cancer treatment through scientific research and development.